Artery Repair: Not Just for Devices Anymore?
Artery repair, particularly angioplasty and stenting, has been one of the device industry's most lucrative sources of income. Now, reports the Boston Globe, biotechnology and tissue engineering are trying to get in on the act. The article, in today's paper, spotlights a Cambridge, MA-based company called Pervasive Therapeutics, Inc.
October 2, 2006
1 Min Read
that has begun human trials of a method to repair lesions in arteries by wrapping them in a gelatinous sheath of living, healthy cells. It works, says the company's cofounder, like "a cellular Band-Aid," fixing arteries by rebuilding them inside-out. If successful, this could have huge implications for the device giants that rely on stents for a major part of their revenues.
Sign up for the QMED & MD+DI Daily newsletter.
You May Also Like